Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-26 @ 3:51 AM
Study NCT ID:
NCT01355718
Status:
COMPLETED
Last Update Posted:
2014-08-11
First Post:
2011-05-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-13
First Submit QC Date:
None
Study First Post Date:
2011-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-08
Last Update Post Date:
2014-08-11
Last Update Post Date Type:
ESTIMATED